Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...
Medical Device Network on MSN
Co-Diagnostics delivers PCR Pro instruments and TB kits to India
The development aligns with recent guidance from the WHO concerning tuberculosis molecular diagnostics in India.
Backed by strong diagnostics market growth and industry consolidation, the transaction positions Axonia Medical to expand across PCR, microbiology, and laboratory automation segments SINGAPORE, SG / ...
EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
Co-Diagnostics Inc. CODX on Wednesday announced that it has commenced shipments of PCR Pro instruments, Co-Dx PCR MTB test ...
Countable Labs achieves CE marking for its Countable 4 Platform, bringing innovative, single-molecule, counting-based PCR to European markets.
Many people will have experienced being unwell with an unknown infection and having to undergo multiple tests to determine the culprit. This sequential process of elimination can be time-consuming and ...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...
Expansion into Bangladesh, Pakistan, Nepal, and Sri Lanka increases TAM in region to $13 billion and supports ...
Co-Diagnostics Inc. on Friday signed an agreement for CoSara Diagnostics Pvt. Ltd, to expand its commercial and distribution ...
Co-Diagnostics’ Co-Dx PCR Platform Technologies receives Japanese Patent: Salt Lake City Friday, March 13, 2026, 15:00 Hrs [IST] Co-Diagnostics, Inc., (Co-Dx), a molecular diagn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results